Cristiano Fontana — investor profile photo

Cristiano Fontana

MedTech Strategic Advisor, Board Member and Investor

📍 Italy🔄 Updated November 2026💼 6 investments📅 16 years investing🗓 Last invested Sep 2026
VC🌍 ItalyInvested this quarter
6
Total investments
1
Early stage
1
Mid stage
4
Late stage
16y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Advisor
Sep 2026
"MedTech Syndicates" (MTS) is a closed members only site designed to form syndicates exclusively for clinicians that allows for the review, evaluation and investment in early start stage MedTech companies in a clinical area that they have expert knowledge or in other clinical areas with the knowledge of other members who endorse the product/service.
Investor & Senior Advisor
Jun 2024
Artiness mission is to to deliver pioneering and reliable solutions to support medical doctors in optimizing their patients’ care. Artiness wants to be the new standard of care in Europe for the procedural support of mini-invasive surgeries, through holographic innovative solutions for medical imaging.
Investor
May 2023
NEURANIX, Transforming audiology diagnostics Neuranix is classified as an innovative company that develops and produces medical devices for people and pets. Through the acquisition of a new patented technology and thanks to the collaboration with specialists in the sector, we are able to develop solutions and specific applications in the audiological field, able to respond to the needs of humans and domestic companion animals. Research projects are carried out in collaboration with CNR (Italy’s National Research Institute), with important universities and specialist veterinary structures. Today Neuranix owns three patents in the audiological field. These patents are currently applied in two products; Vet-Wave and Med-Wave. The first, developed for the veterinary world, is already being commercialized, while the second, for human use, will be launched mid 2023. For more info please contact info@neuranix.com.
late stageMedical Device
Board Member
Sep 2021
I-VASC it’s an Italian based medical device company founded in 2015 with the goal of bringing to market its patented Empty Vein Ablation (EVA) technology for the minimally invasive treatment of CVI (Chronic Venous Insufficiency) and in particular varicose veins. I-VASC successfully moved from a conceptual idea to an innovative and fully validated device, by obtaining in 2021 the CE Mark certification for its VELEX™️ system, catheter and handle I-VASC Team is committed to make VELEX™️ and E.V.A. procedure commercially available for patients and health care providers around the world, as well as to develop new applications for its technology platform
Advisor& Investor
Jan 2021
We manufacture and market robotic devices and exoskeletons for rehabilitation, movement assistance and human capacity augmentation. We specialize in the development of high-efficiency wearable robots for load handling, walking assistance or motor function recovery. Our products are used in various fields, for example in industry as force amplifiers or in the medical field as neuromotor/functional rehabilitation systems for disabled or elderly people. We design new concept, high-tech robots that combine complexity with high ergonomics and ease of use.
CFO, Board member
Mar 2010
CrossBay Medical is a Women’s Health Company that believes 51% of the world’s population is grossly underserved due to the state of trans-cervical uterine health products. We are replacing age-old technologies with our CrossGlideTM family of products. We are changing how uterine health procedures are done and improving the quality of life for womankind
early stageMedical Device
Experience · 9 entries
All (9)
Investments (6)
Founder (1)
Board (2)
2026
Investor & Advisor
Sep 2026
"MedTech Syndicates" (MTS) is a closed members only site designed to form syndicates exclusively for clinicians that allows for the review, evaluation and investment in early start stage MedTech companies in a clinical area that they have expert knowledge or in other clinical areas with the knowledge of other members who endorse the product/service.
2024
Investor & Senior Advisor
Jun 2024
Artiness mission is to to deliver pioneering and reliable solutions to support medical doctors in optimizing their patients’ care. Artiness wants to be the new standard of care in Europe for the procedural support of mini-invasive surgeries, through holographic innovative solutions for medical imaging.
2023
Investor
May 2023
NEURANIX, Transforming audiology diagnostics Neuranix is classified as an innovative company that develops and produces medical devices for people and pets. Through the acquisition of a new patented technology and thanks to the collaboration with specialists in the sector, we are able to develop solutions and specific applications in the audiological field, able to respond to the needs of humans and domestic companion animals. Research projects are carried out in collaboration with CNR (Italy’s National Research Institute), with important universities and specialist veterinary structures. Today Neuranix owns three patents in the audiological field. These patents are currently applied in two products; Vet-Wave and Med-Wave. The first, developed for the veterinary world, is already being commercialized, while the second, for human use, will be launched mid 2023. For more info please contact info@neuranix.com.
late stageMedical Device
2021
Board Member
Sep 2021
I-VASC it’s an Italian based medical device company founded in 2015 with the goal of bringing to market its patented Empty Vein Ablation (EVA) technology for the minimally invasive treatment of CVI (Chronic Venous Insufficiency) and in particular varicose veins. I-VASC successfully moved from a conceptual idea to an innovative and fully validated device, by obtaining in 2021 the CE Mark certification for its VELEX™️ system, catheter and handle I-VASC Team is committed to make VELEX™️ and E.V.A. procedure commercially available for patients and health care providers around the world, as well as to develop new applications for its technology platform
Advisor& Investor
Jan 2021
We manufacture and market robotic devices and exoskeletons for rehabilitation, movement assistance and human capacity augmentation. We specialize in the development of high-efficiency wearable robots for load handling, walking assistance or motor function recovery. Our products are used in various fields, for example in industry as force amplifiers or in the medical field as neuromotor/functional rehabilitation systems for disabled or elderly people. We design new concept, high-tech robots that combine complexity with high ergonomics and ease of use.
Show all 9 entries ↓
Investment activity
2010–2026 · 6 investments
2010120212202312024120261
Recent (last 2 years)Earlier
Investor lists
Lists that match Cristiano's portfolio